Markets:

Overview

News

Currencies

International

Treasuries

Omnicell, Inc. - Common Stock (NQ:OMCL)

46.98 +1.84 (+4.08%)

Streaming Delayed Price Updated: 3:33 PM EST, Jan 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Omnicell, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Omnicell’s (NASDAQ:OMCL) Q1 Sales Top Estimates But Stock Drops

May 06, 2025

Healthcare tech company Omnicell (NASDAQ:OMCL) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 9.6% year on year to $269.7 million. On the other hand, next quarter’s...

Via StockStory

Omnicell Announces First Quarter 2025 Results

May 06, 2025

From Omnicell, Inc.

Via Business Wire

Earnings Scheduled For May 6, 2025 ↗

May 06, 2025

Via Benzinga

Omnicell (OMCL) Q1 Earnings Report Preview: What To Look For

May 05, 2025

Healthcare tech company Omnicell (NASDAQ:OMCL) will be announcing earnings results tomorrow morning. Here’s what to expect.

Via StockStory

Topics Artificial Intelligence

Earnings Scheduled For February 6, 2025 ↗

February 06, 2025

Via Benzinga

Assessing Omnicell: Insights From 4 Financial Analysts ↗

February 04, 2025

Via Benzinga

Beyond The Numbers: 6 Analysts Discuss Omnicell Stock ↗

November 21, 2024

Via Benzinga

Winners And Losers Of Q4: Evolent Health (NYSE:EVH) Vs The Rest Of The Healthcare Technology for Providers Stocks

April 29, 2025

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Evolent Health (NYSE:EVH) and...

Via StockStory

Unpacking Q4 Earnings: Omnicell (NASDAQ:OMCL) In The Context Of Other Healthcare Technology for Providers Stocks

April 28, 2025

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Omnicell (NASDAQ:OMCL) and the best and...

Via StockStory

1 of Wall Street’s Favorite Stock to Target This Week and 2 to Keep Off Your Radar

April 27, 2025

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because...

Via StockStory

Q4 Earnings Outperformers: Tandem Diabetes (NASDAQ:TNDM) And The Rest Of The Healthcare Technology Stocks

April 15, 2025

Let’s dig into the relative performance of Tandem Diabetes (NASDAQ:TNDM) and its peers as we unravel the now-completed Q4 healthcare technology earnings season.

Via StockStory

Omnicell to Release First Quarter 2025 Financial Results on May 6, 2025

April 14, 2025

From Omnicell, Inc.

Via Business Wire

Omnicell, Royalty Pharma, EXL, IMAX, and OPENLANE Stocks Trade Down, What You Need To Know

April 10, 2025

A number of stocks fell in the afternoon session after stocks gave back some of the gains from the previous day as the White House clarified the tariffs on imports from China would add up to 145%,...

Via StockStory

Topics Economy Government World Trade

Omnicell (OMCL): Buy, Sell, or Hold Post Q4 Earnings?

April 08, 2025

What a brutal six months it’s been for Omnicell. The stock has dropped 24.6% and now trades at $32.45, rattling many shareholders. This was partly driven by its softer quarterly results and may have...

Via StockStory

Omnicell Welcomes Perry A. Genova, PhD, as Chief Technology Officer

March 24, 2025

From Omnicell, Inc.

Via Business Wire

What Analysts Are Saying About Omnicell Stock ↗

March 20, 2025

Via Benzinga

Omnicell Announces Chief Financial Officer Transition

March 12, 2025

From Omnicell, Inc.

Via Business Wire

3 Healthcare Stocks Skating on Thin Ice

February 28, 2025

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19,...

Via StockStory

Topics Stocks

Astrana Health (ASTH) To Report Earnings Tomorrow: Here Is What To Expect

February 26, 2025

Healthcare services company Astrana Health will be reporting results tomorrow afternoon. Here’s what investors should know.

Via StockStory

Privia Health (PRVA) Q4 Earnings Report Preview: What To Look For

February 26, 2025

Healthcare tech company Privia Health Group (NASDAQ:PRVA) will be announcing earnings results tomorrow before market open. Here’s what to expect.

Via StockStory

Evolent Health (EVH) Q4 Earnings Report Preview: What To Look For

February 19, 2025

Healthcare solutions company Evolent Health (NYSE:EVH) will be reporting results tomorrow after market close. Here’s what to expect.

Via StockStory

Waystar (WAY) Reports Q4: Everything You Need To Know Ahead Of Earnings

February 17, 2025

Healthcare technology company Waystar Holding (NASDAQ:WAY) will be reporting results tomorrow morning. Here’s what to look for.

Via StockStory

Omnicell (NASDAQ:OMCL) Exceeds Q4 Expectations But Full-Year Sales Guidance Misses Expectations

February 06, 2025

Healthcare tech company Omnicell (NASDAQ:OMCL) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 18.6% year on year to $306.9 million. On the other hand, next...

Via StockStory

Omnicell Announces Fiscal Year and Fourth Quarter 2024 Results

February 06, 2025

From Omnicell, Inc.

Via Business Wire

Earnings To Watch: Omnicell (OMCL) Reports Q4 Results Tomorrow

February 05, 2025

Healthcare tech company Omnicell (NASDAQ:OMCL) will be reporting results tomorrow morning. Here’s what to expect.

Via StockStory

Omnicell to Release Fourth Quarter and Full Year 2024 Financial Results on February 6, 2025

January 13, 2025

From Omnicell, Inc.

Via Business Wire

Omnicell to Present at the 43rd Annual J.P. Morgan Healthcare Conference

January 08, 2025

From Omnicell, Inc.

Via Business Wire

Omnicell Announces OmniSphere

December 09, 2024

From Omnicell, Inc.

Via Business Wire

Omnicell to Present at the Piper Sandler 36th Annual Healthcare Conference

November 22, 2024

From Omnicell, Inc.

Via Business Wire

Omnicell Announces Pricing of $150 Million Convertible Senior Notes Offering

November 20, 2024

From Omnicell, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.